Clinical Trials in New York

Showing 13261-13280 of 22,668 trials

E-Support Groups in Multiple Sclerosis

NCT03574961

Primary objectives: * To determine the feasibility of program (80% retained with 75% overall attendance, and completed immediate follow-up questionnaires from 75% of participants). * To determine the efficacy of program (evaluated by decreased loneliness, operationalized as decreased total score on the UCLA Loneliness Scale from pre to post intervention). Secondary objective: * To determine whether program will affect depression and quality of life.

Multiple Sclerosis

Columbia University30 participantsStarted May 2018

New York, New York, United States

TERMINATEDPhase 3< 1 mile

Study of Rapastinel as Monotherapy in Patients With MDD

NCT03560518

The study will evaluate the efficacy, safety, and tolerability of 450 milligrams (mg) and 900 milligrams (mg) of Rapastinel, compared to placebo in participants with major depressive disorder (MDD).

Depressive Disorder, Major

Naurex, Inc, an affiliate of Allergan plc439 participantsStarted Jun 2018

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Anaheim, California, United States +37 more locations

E-Support Groups in Multiple Sclerosis

Study of Rapastinel as Monotherapy in Patients With MDD

Find Trials by Condition in New York

Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial

AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis

A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors

Long-Duration Stimulant Treatment Study of ADHD in Young Children

Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

A Clinical Trial of KT07 Capsule in the U.S.A

Cognitive Rehabilitation for Gulf War Illness

The ReWalk Exoskeletal Walking System for Persons With Paraplegia

Pancreas Resection With and Without Drains

SHARE for Persons With Chronic Conditions and Their Family Caregivers

Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

AMG 827 in Subjects With Psoriatic Arthritis

Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration